INTERPARFUMS INC quarterly report, Q2 FY2000

Business Context and Reporting Period

Company: Inter Parfums, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2000
Business Overview: A leading manufacturer and distributor of prestige and mass-market fragrances, cosmetics, and personal care products. Operations are split between the United States and Europe (primarily France).

Key Financial Metrics (Six Months Ended June 30, 2000)

Metric Value
Net Sales $46,445,604
Gross Margin $21,659,827 (46.6% of sales)
Net Income $2,930,213
Diluted EPS $0.23
Cash and Cash Equivalents $25,016,988
Marketable Securities $1,904,790
Total Current Assets $84,192,625
Total Current Liabilities $31,040,552
Working Capital $53,152,073
Long-Term Debt $1,451,379
Bank Loans Payable (Current) $3,178,810

Material Changes vs. Prior Period

  • Revenue Growth: Net sales increased 11% to $46.4 million compared to $41.8 million in the prior year. On a constant currency basis, sales grew 21%.
  • Profitability: Net income increased 31% to $2.9 million from $2.2 million. Diluted EPS rose 21% to $0.23.
  • Inventory Build: Inventories increased significantly by approximately $7.9 million (from $19.5M to $27.3M) to prepare for new product launches.
  • Cash Flow: Operating cash flow turned negative, using $3.1 million compared to providing $1.6 million in the prior year, primarily due to inventory buildup.
  • Investment Gains: The company realized a gain of $1.58 million from the sale of marketable securities, boosting net income.

Guidance, Outlook, and Risks

Management Commentary and Outlook

  • Growth Drivers: Management expects to maintain a constant dollar growth rate of better than 20% for the remainder of 2000, driven by new launches including the S.T. Dupont "Signature" line, Paul Smith fragrance, and Burberry "Touch".
  • New Licenses: Signed exclusive worldwide licenses with CELINE (launching Jan 2001) and FUBU (launching late 2001).
  • Mass Market: Mass market products grew 25%, with expansion into discount stores via the Aziza II line.

Risks and Contingencies

  • Litigation (Ombre Rose): Inter Parfums, S.A. is involved in litigation with licensor Jean Charles Brosseau, S.A. regarding the Ombre Rose trademark. A judgment of approximately $600,000 was awarded to Brosseau in Oct 1999. Inter Parfums has taken a $600,000 charge against earnings, considering the judgment likely to be sustained, though they are appealing. The licensor seeks termination of the license and claims $7.0 million in damages.
  • Tax Audit: French Tax Authorities are auditing Inter Parfums, S.A. The company added a $470,000 accrual to cover potential exposure for 1997 and 1998 tax years.
  • Currency: The strong US dollar relative to the French franc masks real revenue growth rates.

Investor Verification Checklist

  • Litigation Outcome: Monitor the appeal of the $600,000 judgment and the potential termination of the Ombre Rose license.
  • Inventory Turnover: Verify that the $7.9 million increase in inventory converts to sales as new products launch in Q3 and Q4.
  • Tax Exposure: Track the resolution of the French tax audit to ensure the $470,000 accrual is sufficient.
  • New License Execution: Confirm the successful launch and market acceptance of the CELINE and FUBU fragrance lines in 2001.
  • Operating Cash Flow: Watch for a return to positive operating cash flow once inventory levels stabilize.